MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

By

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

JenaValve tapped a medtech veteran with a string of successful exits behind him as interim chairman & CEO, replacing another medical device vet, David Drachman, after just 7 months.

Drachman, who spent 10 years in the corner office at AtriCure (NSDQ:ATRC), "resigned from the company for non-business related personal reasons, JenaValve said.

JenaValve, which makes a transcatheter aortic valve implant that’s on the market in Europe, had named Drachman to be its new CEO last July.

Keltjens has a long pedigree in the medical device space. Formerly the chief executive at AngioDynamics (NSDQ:ANGO), he took over at Endosense and led it to a $331 million acquisition by St. Jude Medical (NYSE:STJ). By October 2013 Keltjens had landed at Sapiens Brain Steering Stimulation, which Medtronic (NYSE:MDT) acquired for $200 million less than a year later. He’s been a director at Munich- and Irvine, Calif.-based JenaValve since January 2014, according to the company’s website.

"I would like to thank Dave Drachman for his many valuable contributions to JenaValve over the past 6 months. It is unfortunate that his personal circumstances led him to resign his position. We sincerely wish Dave all the best for his future. As interim CEO, I will work closely with the leadership team to ensure that we maintain momentum and continue to drive our company forward while we search for a new U.S.-based chief executive," Keltjens said in prepared remarks. "In the past 6 months, we have made great progress in finalizing the design and testing of our next-generation pericardial valve platform. Moreover, we have worked closely with the regulatory agencies in both the U.S. and the European Union to define clear clinical and regulatory pathways. I am confident in our future based on great technology, strong teams in Munich and Irvine and the TAVI market being one of the fastest growth opportunities in medical devices as well as unwavering support from our board and shareholders."

 Brigham & Women’s president Nabel is NFL’s 1st medical chief

The National Football League yesterday named Dr. Elizabeth Nabel, president of Boston’s Brigham & Women’s Hospital, to be its 1st chief health & medical advisor. The Brigham also tapped chief quality officer Dr. David Bates to be its chief innovation officer.
Read more

 Inari Medical taps ex-Visualase CEO Hoffman
Inari Medical said it named ex-Visualase chief Bill Hoffman to be its new president & CEO. Medtronic acquired Visualase for $105 million last year.
Read more

 Intersect ENT names McKhann as CCOY
Intersect ENT (NSDQ:XENT) said it named Chas McKhann, a longtime exec at Johnson & Johnson‘s (NYSE:JNJ) Cordis unit and then at Boston Scientific (NYSE:BSX), to be its new chief commercial officer.
Read more

 Biolase CFO Furry is out

Biolase (NSDQ:BIOL) said CFO Frederick Furry resigned effective Jan. 31 "to pursue other opportunities."
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Versapor® RC Membranes: The next generation of venting materials
    As the world leader in the design and production of membranes, filtration devices, and separation systems, Pall Corporation supplies products to nearly every industry in the world. Founded in 1946, Pall Corporation has set the standard for filtration solutions for 75 years and counting. Our customers have relied on us for their most sophisticated applications… […]
  • Tips to help bring your medical device from mind to market
    By Bret Ludwig, Ph.D. Senior Product Development Specialist, 3M Medical Materials & Technologies Great medical devices start with an idea—a spark. And from there, it might move to the back of a napkin or a notepad. But as development continues, the process can get trickier and more complex. In fact, turning an idea into a… […]
  • Salt baths increase stability in the medical device tempering process
    Calibration baths, like salt baths, were originally for calibrating temperature assets. But there’s another use for them: manufacturing Nitinol medical devices. Travis Porter, Fluke Calibration Nitinol is a nickel-titanium alloy that exhibits both thermal shape memory behavior and super-elasticity. It’s a great metal to use in medical devices because it’s possible to set the wire… […]
  • Traco Power announces new TMW 24 and TMW 36 series
    Traco Power (San Jose, Calif.) recently announced the company’s new TMW series of 24- and 36-W power supplies. The new power supplies are IP68 rated and fully encapsulated — with flexible options for PCB or chassis mounting for the medical and industrial markets. The TMW Series were also designed for flush box-mounting to support IoT… […]
  • Protolabs reports mixed-bag results for Q2
    Protolabs (NYSE: PRLB) posted second-quarter earnings today that missed the consensus forecast on Wall Street, though the company beat on revenue. The Maple Plain, Minn–based digital manufacturing outsourcer — which serves medtech and a host of other industries — reported profits of $12.9 million, or 47¢ per share, on sales of $123.0 million for the… […]
  • Integer beats The Street in Q2, boosts sales outlook
    Integer Holdings (NYSE:ITGR) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its 2021 sales outlook amid continued recovery from the COVID-19 pandemic. The Plano, Texas–based medical device contract manufacturing giant reported profits of $29.4 million, or 89¢ per share, on sales of $312.0 million for the three months ended… […]
  • Keep the end in mind when choosing a medtech partner
    There are five general categories of medtech vendor partners. If the end is apparent in the beginning, the correct type of partner will be clearer. Jim Reed, Minnetronix Medical Stephen Covey gave the business world this mantra in one of his bestsellers: “Start with the end in mind.” Whether they didn’t read the book or… […]
  • Orthofix launches Fiberfuse Strip bone graft
    Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S. Lewisville, Texas–based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures. FiberFuse Strip is 100% bone and has a unique mixture of mineralized cancellous and demineralized cortical bone with… […]
  • Thermo Fisher Scientific beats The Street in Q2 results
    Thermo Fisher Scientific (NYSE:TMO) today posted second-quarter results that beat the overall consensus on Wall Street. The Waltham, Mass.–based company reported profits of $1.8 billion, or $4.61 per share, on sales of $9.3 billion for the three months ended July 1, 2021, for a bottom-line gain of 58.1% on sales growth of 34.1% compared with… […]
  • Choosing the Right Rubber Material and Process for Your Medical Parts
    When it’s time to design and develop a new medical device that calls for an elastomer component, there are a number of material options and manufacturing processes to consider. The long list of material properties impacting performance includes your prospective polymer’s end-use environment, chemical compatibility, hardness, compression set, tensile properties and manufacturability — to name… […]
  • 3M’s healthcare segment registers growth in Street-beating Q2
    3M (NYSE:MMM) reported second-quarter results that beat the consensus forecast — with the company’s healthcare segment showing especially robust growth. The St. Paul, Minn.–based company posted profits of $1.5 billion, or $2.59 per share, on sales of $9 billion for the three months ended June 30, 2021, for a 16.7% bottom-line gain on sales growth of… […]

Leave a Reply